Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Nestle Sa ADR
(OP:
NSRGY
)
99.10
+1.29 (+1.32%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 15, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Nestle Sa ADR
< Previous
1
2
3
4
5
6
7
8
Next >
Ben & Jerry's Co-Founders Not Worried About Ozempic's Impact On Ice Cream Business: Here's Why
↗
June 27, 2024
Ben Cohen and Jerry Greenfield, the co-founders of Ben & Jerry's, are not worried about the impact of weight-loss drugs on their ice cream business, despite the impending spin-off of their parent...
Via
Benzinga
Nestle Carefully Targets Weight-Loss Drug Users with New Food Line
↗
June 21, 2024
Nestle's new Vital Pursuit brand targets individuals on weight-loss drugs without mentioning medications on packaging, addressing regulatory concerns and focusing on marketing through social media.
Via
Benzinga
What's Going On With Beyond Meat Shares Tuesday?
↗
June 11, 2024
Beyond Meat Inc. (NASDAQ: BYND) shares are trading lower Tuesday afternoon after a New York Post article discussed a study linking processed foods, including vegan meat alternatives, to increased risk...
Via
Benzinga
7 High-Beta Growth Stocks to Buy for 20-Bagger Returns
↗
June 06, 2024
These high-beta growth stocks represent companies poised for multi-fold upside in revenue and cash flows between now and 2028.
Via
InvestorPlace
Sip on Profits: 3 Top Coffee Stocks to Perk Up Your Returns
↗
May 28, 2024
Check how investing in coffee stocks like Starbucks, Nestle, and J.M. Smucker can turn your daily coffee savings into long-term gains.
Via
InvestorPlace
10 Best Vanguard Funds to Buy Right Now
↗
May 27, 2024
These 10 Vanguard stock ETFs can help you build a top-notch portfolio.
Via
The Motley Fool
Topics
ETFs
Plunge Protection: 3 Stocks to Hold When the Market Dives
↗
May 27, 2024
The bull market won't last forever. These are three defensive stocks to buy before the inevitable next market swoon.
Via
InvestorPlace
Move Over Ozempic! 3 New GLP-1 Drugs and Products Coming Soon.
↗
May 23, 2024
The search for the next GLP-1 drugs that will be blockbuster winners during the next market cycle is on, and here are three contenders.
Via
InvestorPlace
Fisker Stock Alert: Fisker Ends Roadside Assistance for Ocean Drivers
↗
May 22, 2024
Fisker stock is in the news Wednesday as the electric vehicle (EV) maker continues to deal with problems amid recent financial struggles.
Via
InvestorPlace
Topics
Electric Vehicles
Nestle Enters the Weight Loss Game With Food for Ozempic Users. What to Know.
↗
May 22, 2024
Nestle is getting into the weight loss business with new packs of frozen food designed for Ozempic users and others trying to slim down.
Via
InvestorPlace
Weight Loss Drugs Like Wegvoy and Zepbound Users - Nestlé Launches $5 Pizza For You
↗
May 21, 2024
Nestlé SA launches Vital Pursuit, a new food line tailored for GLP-1 weight loss medication users, featuring protein, fiber, and essential nutrients. Available Q4 nationwide.
Via
Benzinga
Fresh on the Market: 3 Newly Listed Stocks Poised to Skyrocket
↗
May 15, 2024
Expected to soar, these newly listed stocks to buy represent companies with solid fundamentals and a stellar growth outlook.
Via
InvestorPlace
Furry Tech Boom: 3 Pet Stocks Unleashing the Power of AI
↗
May 01, 2024
Despite the post-pandemic slowdown, the pet care industry remains healthy, as these three AI pet stocks to buy now demonstrate.
Via
InvestorPlace
Topics
Artificial Intelligence
IBTA Stock IPO: When Does Ibotta Go Public? What Is the Ibotta IPO Price Range?
↗
April 09, 2024
Although the upcoming Ibotta IPO brings excitement to the new-listing space, IBTA stock faces a tricky environment.
Via
InvestorPlace
Topics
Initial Public Offering
Trash Bin Alert: 3 Cocoa Stocks to Dump Before the Bitter End
↗
April 09, 2024
Cocoa prices are still pushing aggressively higher, and may still have room to run. It's why we’re looking at top cocoa stocks to sell.
Via
InvestorPlace
Branding Behemoths: 3 Consumer Staples Stocks With Super Strong Moats
↗
March 26, 2024
Investors looking for consumer staples stocks with moats should consider these three super strong investments.
Via
InvestorPlace
Top Wall Street Analysts Flag US Market Concentration Anxiety, Advise Investors To Adopt 'Barbell Approach'
↗
March 11, 2024
Goldman Sachs urges investors to diversify geographically due to high concentration in US tech stocks, with Japan, healthcare, and European GRANOLAS highlighted as promising markets.
Via
Benzinga
Boiling Water Reduces Microplastics: What Does It Mean For Coca-Cola, PepsiCo's Bottled Water Brands?
↗
February 29, 2024
Microplastics are small plastic fragments found everywhere and can cause harm to human health. Boiling and filtering tap water can reduce them by 90%.
Via
Benzinga
The Steady Eddies: 3 Dividend Stocks for a Decade of Dependable Growth
↗
February 29, 2024
If you're looking for a steady list of dividend stocks to depend on for the next decade, these are the clear names.
Via
InvestorPlace
11 'Granolas' Stocks Outperform Magnificent 7 With Lower Volatility, Higher Yields
↗
February 28, 2024
A group of stocks, which Goldman Sachs dubbed the "Granolas," accounted for 50% of gains of the Stoxx Europe 600 Index for the past year.
Via
Benzinga
Freshpet Stock: Leading the Pack with Solid Earnings Results
February 28, 2024
Freshpet, a leader in the refrigerated pet food space, has seen its stock soar recently due to impressive financial results.
Via
MarketBeat
Topics
Earnings
Move Over Magnificent 7, Say Hello to the GRANOLAS
↗
February 22, 2024
Dive into the compelling world of GRANOLAS stocks: Europe's elite players shaping the future of pharmaceuticals, tech, and consumer goods.
Via
InvestorPlace
Top 3 Struggling Stocks to Avoid as Cocoa Prices Soar
↗
February 20, 2024
Investors want to keep in mind these stocks to avoid amid higher cocoa prices. Some analysts don’t expect improvement any time soon.
Via
InvestorPlace
22 Blue-Chip European Dividend Growth Stocks
↗
February 16, 2024
A discussion of insights on European dividend growth stocks.
Via
Talk Markets
Should The Day After The Super Bowl Be A Holiday? Here's What Benzinga Readers Said And What History Shows
↗
February 11, 2024
The day following the Super Bowl often witnesses decreased productivity and a significant uptick in employee absences.
Via
Benzinga
Game Day Gainers: 3 Food & Beverage Stocks Primed for a Super Bowl Boost
↗
February 06, 2024
With the big game coming up, Super Bowl stocks become a thing for sports-loving investors looking to profit.
Via
InvestorPlace
3 Purrfect Stocks to Buy for the Booming Pet Care Industry
↗
January 11, 2024
Despite the post-pandemic slowdown, stocks within the pet care industry are good long-term investments because the revenue trend is higher.
Via
InvestorPlace
Codexis Clinches Deal With Nestlé Health Science, Eyes Up To $45M Milestone In EPI Treatment Breakthrough
↗
December 27, 2023
Codexis, Inc. (NASDAQ: CDXS) entered a purchase deal with Nestlé S.A.(OTC: NSRGY) Nestlé Health Science for CDX-7108, a potential treatment for exocrine pancreatic insufficiency (EPI).
Via
Benzinga
Weight Loss Drugs By Novo Nordisk, Eli Lilly Don't Deter Nestle's Coffee Demand - CEO Explains Why
↗
December 20, 2023
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company's (NYSE: LLY) Zepbound and Novo Nordisk's
Via
Benzinga
25% of Warren Buffett's Secret Portfolio Is Invested in These 3 ETFs. Here's Why They're Great Picks for 2024.
↗
December 18, 2023
Buffett didn't personally pick these ETFs. But all three could make him money in the new year.
Via
The Motley Fool
Topics
ETFs
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today